Click below to explore OSSIO press releases and recent news articles written about OSSIOfiber® Intelligent Bone Regeneration Technology.

Press Releases

OSSIO Receives Vizient Contract for Bio-Integrative Orthopedic Fixation Technology

OSSIO, Inc., an orthopedic fixation company dedicated to improving orthopedic outcomes and experiences, receives Vizient contract for bio-integrative orthopedic technology.

2 March 2022
OSSIO Awarded FDA 510(k) Clearance for OSSIOfiber® Compression Screw Portfolio

Company Successfully Surpasses 1,000th Implantation Milestone for its Strong and Bio-integrative OSSIOfiber® Technology

19 October 2020
OSSIO Announces U.S. Launch and First Commercial Use of the OSSIOfiber® Trimmable Fixation Nail System for Broad Utilization in Foot/Ankle and Hand/Wrist Procedures

New biointegrative system offers screw-like stability with the utility of a trimmable nail, leaving no permanent implant behind.

22 July 2020
OSSIO Appoints Healthcare Industry Veteran Gary J. Pruden to Board of Directors

OSSIO, Inc., an orthopedic fixation company dedicated to improving orthopedic outcomes and experiences, today announced the appointment of Gary J. Pruden to its Board of Directors. Pruden.

OSSIO Receives FDA 510(k) Clearance for OSSIOfiber® Hammertoe Fixation System

Complete Offering of Implant Sizes and Shapes Provides Surgeons and their Patients an Intelligent Bone Regeneration Alternative to Metal Fixation

OSSIO Receives Prestigious Frost & Sullivan New Product Innovation Award for its Breakthrough OSSIOfiber Intelligent Bone Regeneration Technology

Award recognizes company’s dedication to transforming the orthopedic market through its first-of-kind bio-integrative bone fixation solution

11 June 2019
OSSIO Announces U.S. Launch and First Commercial Use of the New OSSIOfiber Bone Pin for Hammertoe Correction

The first commercial cases were hammertoe repairs successfully performed at Polaris Surgery Center in Westerville, Ohio.

16 May 2019
OSSIO secures $22 million in financing

OSSIO, an orthopedic fixation company, today announced the closing of $22 million in equity financings led by OCV Partners, a Los Angeles based venture capital firm, with continued participation from existing investors Ortho Vision LLC and Secocha Ventures.

11 March 2019
OSSIO Receives FDA 510(k) Clearance for OSSIOfiber™ Bone Pin Product Family

OSSIO, an orthopedic fixation company, today announced that its OSSIOfiberTM Bone Pin Family has received 510(k)  market clearance from the U.S. Food and Drug Administration (FDA).

14 January 2019

In the News

Becker’s Spine Review

A new class of bio-integrative implants’: Dr. Stuart Miller on orthobiologics and implant selection.

19 January 2019
MedTech Dive

FDA clears absorbable foot and ankle implant

15 January 2019
Becker’s Spine Review

Biointegrative orthopedic fixation material receives FDA clearance: 5 things to know

14 January 2019

Ortho dev Ossio wins FDA nod for bio-integrative bone pins

15 January 2019
Orthopedics This Week

FDA clears Ossio’s Bio-Integrative Bone Fixation Implant

16 January 2019
Fierce Biotech

FDA clears Ossio’s integrative mineral bone pins for orthopedic surgeries

14 January 2019
Top Ten Innovations In Podiatry

Whether it’s a new advance for treating the Charcot foot, a promising wound care dressing, a cartilage allograft to address osteochondral defects or a medication for psoriasis, the latest roundup of innovations may offer treatment options for potentially improved outcomes.

26 June 2018

Contact Us

Have any questions or ideas? Feel free to contact us!

Commercial Headquarters

300 TradeCenter, Suite 3690
Woburn, MA. 01801

Science & Technology Center

8 HaTochen Street.
Caesarea, Israel 3079861

Customer Service

For product inquiries or purchasing questions contact 833-781-7373 or email

We Are Hiring!

Join us in creating a new reality in orthopedics

OSSIO is a young, fast-growing company that is always on the lookout for talented people to join its multidisciplinary team. If you are highly motivated and inspired to heal bone better, please send your CV to